Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series

Adults with sickle cell disease can develop pulmonary hypertension from a multitude of etiologies. Classified as WHO Group 5, there are no therapies approved for the treatment of sickle cell disease-pulmonary hypertension. Thromboembolic disease is prevalent in sickle cell disease and can lead to pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Weir, Nargues A., Conrey, Anna, Lewis, Denise, Mehari, Alem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083805/
https://www.ncbi.nlm.nih.gov/pubmed/30033820
http://dx.doi.org/10.1177/2045894018791802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083805/
https://www.ncbi.nlm.nih.gov/pubmed/30033820
http://dx.doi.org/10.1177/2045894018791802

Ejemplares similares